PROTALIX BIOTHERAPEUTICS INC (PLX) Stock Cash Flow
NYSEARCA:PLX - NYSE Arca - US74365A3095 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -9.61M | 8.31M | -14.93M | -27.58M | -6.52M | |||
| Depreciation Amortization | 1.28M | 1.19M | 1.09M | 1.12M | 1.30M | |||
| Income Taxes - Deferred | 236.00K | -3.09M | N/A | N/A | N/A | |||
| Change In Working Capital | 12.03M | -10.54M | -12.02M | 9.90M | -27.13M | |||
| Interest Paid | 1.53M | 2.74M | 2.20M | 3.41M | 4.34M | |||
| Other non cash items | 4.33M | 2.81M | 860.00K | 6.28M | 6.25M | |||
| OPERATING CASH FLOW | 8.28M | -1.32M | -25.00M | -10.29M | -26.11M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.11M | -1.15M | -630.00K | -1.46M | -660.00K | |||
| Other Investing Activity | 20.31M | -15.56M | -4.41M | 20.38M | -19.30M | |||
| INVESTING CASH FLOW | 19.20M | -16.71M | -5.04M | 18.92M | -19.95M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 0.00 | -34.12M | -220.00K | |||
| Stock Issued/Repurchased | N/A | 24.67M | 8.24M | 46.20M | 46.68M | |||
| FINANCING CASH FLOW | N/A | 24.67M | 8.24M | 12.08M | 46.47M | |||
| Exchange Rate Effect | -56.00K | -114.00K | -80.00K | 10.00K | 60.00K | |||
| CHANGE IN CASH | 7.00M | 6.52M | -21.88M | 20.72M | 470.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 8.28M | -1.32M | -25.00M | -10.29M | -26.11M | |||
| Capital Expenditure | -1.11M | -1.15M | -630.00K | -1.46M | -660.00K | |||
| FREE CASH FLOW | 7.17M | -2.47M | -25.63M | -11.75M | -26.77M | |||
All data in USD